Oct. 8, 2009 (Business Wire) -- ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that its facility in Pittsburgh, Pennsylvania that manufacturers and sells the LifeVest^® Wearable Defibrillator, has received Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Accreditation from Medicare. This designation, in combination with its ISO 13485 certification, makes ZOLL’s Pittsburgh facility one of the few healthcare organization facilities to integrate its Medicare accreditation and ISO 13485 certification into a single accredited management system.

The Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) requires all DMEPOS suppliers to meet quality standards for Medicare accreditation, which is mandatory to maintain National Supplier Clearinghouse (NSC) billing privileges. DMEPOS accreditation specifically focuses on standards for administration, financial management, human resource management, consumer services, performance management, product safety, and information management. The accreditation also contains service standards, including intake, delivery and set-up, training and instruction of the beneficiary and/or their caregiver, and follow-up service.

“ZOLL continues to demonstrate its commitment to the highest level of business standards by obtaining the Centers for Medicare and Medicaid Services DMEPOS Accreditation,” said Richard A. Packer, Chairman and Chief Executive Officer of ZOLL. “We are pleased that our process and management systems have enabled us to achieve this milestone.”

The LifeVest durable medical equipment (DME) business model allows a physician to protect a specific patient by placing a medical order directly with ZOLL. From this point, ZOLL manages the process to protect the patient from sudden cardiac arrest through hospital discharge and recovery at home, including fitting the LifeVest to the specific patient, educating the patient in the hospital, managing all of the medical documentation and insurance paperwork, and being available to address any patient needs once home.

The LifeVest is covered by most health plans in the United States, including commercial, state, and federal plans. To date, the LifeVest has been prescribed to more than 18,000 patients. For more information, go to www.zoll.lifecor.com or call 1-800-543-3267.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation and temperature control therapies for the treatment of critical care patients.